Bristol-Myers Squibb (BMY) to announce Q4 earnings on February 6th. Analysts expect $1.47 EPS on $11.56B revenue.
Eli Lilly (LLY) is set to announce Q4 earnings results, with analysts expecting positive growth driven by key drugs and new product launches.
Per-share quarterly profit rose 44 percent from a year earlier, the company said, signaling that it had moved past a period of turmoil.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback